-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VXpB+9EmG6CiGWPxkX/TsPpeofRlBw5Mm3zL3TGvxzufTFwCO+MRQm/UppXhNZWR 2Ij+MP+Jc0BKW0PSEej2CQ== 0001209191-05-013577.txt : 20050303 0001209191-05-013577.hdr.sgml : 20050303 20050303163450 ACCESSION NUMBER: 0001209191-05-013577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050301 FILED AS OF DATE: 20050303 DATE AS OF CHANGE: 20050303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RICHMOND MARK CENTRAL INDEX KEY: 0001238971 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 05658347 MAIL ADDRESS: STREET 1: OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD STE 110 CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1204 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-03-01 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001238971 RICHMOND MARK C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 1 0 0 0 Common Stock 2005-03-01 4 M 0 1500 16.813 A 4390 D Common Stock 2005-03-01 4 S 0 59 53.76 D 4331 D Common Stock 2005-03-01 4 S 0 21 53.80 D 4310 D Common Stock 2005-03-01 4 S 0 11 53.81 D 4299 D Common Stock 2005-03-01 4 S 0 42 53.82 D 4257 D Common Stock 2005-03-01 4 S 0 231 53.83 D 4026 D Common Stock 2005-03-01 4 S 0 212 53.84 D 3814 D Common Stock 2005-03-01 4 S 0 21 53.86 D 3793 D Common Stock 2005-03-01 4 S 0 11 53.91 D 3782 D Common Stock 2005-03-01 4 S 0 80 53.94 D 3702 D Common Stock 2005-03-01 4 S 0 138 54.00 D 3564 D Common Stock 2005-03-01 4 S 0 32 54.01 D 3532 D Common Stock 2005-03-01 4 S 0 10 54.02 D 3522 D Common Stock 2005-03-01 4 S 0 70 54.05 D 3452 D Common Stock 2005-03-01 4 S 0 405 54.10 D 3047 D Common Stock 2005-03-01 4 S 0 11 54.11 D 3036 D Common Stock 2005-03-01 4 S 0 85 54.12 D 2951 D Common Stock 2005-03-01 4 S 0 21 54.30 D 2930 D Common Stock 2005-03-01 4 S 0 11 54.31 D 2919 D Common Stock 2005-03-01 4 S 0 11 54.50 D 2908 D Common Stock 2005-03-01 4 S 0 18 54.70 D 2890 D Stock Option (Right to Buy) 16.813 2005-03-01 4 M 0 1500 0.00 D 2000-04-10 2010-04-09 Common Stock 1500 29000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Exercisable as to 25,000 shares on 04/10/2000 and the remainder on 04/10/2001. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2005-03-03 -----END PRIVACY-ENHANCED MESSAGE-----